Answers are grounded in this paper and cite their sources.
Background. COX-2 inhibitors facilitate disruption of the production of angiogenic factors, the use of which in combination with RT leads to a significant delay in tumor growth in experimental models of cancer. Purpose. Evaluation of the effectiveness of RT in combination with COX-2 inhibitor in patients with NSCLC (non-small-cell lung carcinoma). Materials and methods. The study involved 38 patients with NSCLC divided into 2 subgroups: Subgroup 1 was represented by 20 patients who received a RT course and celecoxib 100 mg/d, Subgroup 2 enrolled 18 patients who received only RT. The subgroups were comparable by sex, age, tumor location, general condition. Squamous cell carcinoma was detected in 19 (95.0%) patients of Subgroup 1 and in 9 (50%) patients of Subgroup 2. Stages I – II were diagnosed 4.4 times more frequently in Subgroup 2, stage III was 1.9 times more frequently detected in Subgroup 1 (p < 0.05). VEGF, COX-2 content was assessed before/after the RT course by means of a sandwich immunoassay (ELISA). Results. A positive effect (partial regression, stabilization) was observed equally in the subgroups: 80.0% and 77.8%. In Subgroup 1, partial regression was 5 times more frequent, the overall annual and recurrence-free survival increased by 15 and 29%, respectively. In patients of Subgroup 1, COX-2 was 2.4-fold decreased, in patients of Subgroup 2, COX-2 almost did not change. COX-2 blocking was accompanied by decreased VEGF: 1.9-fold in Subgroup 1, 1.4-fold in Subgroup 2. Changes in COX-2 and VEGF levels were consistent with the objective response after RT with celecoxib: in case of a positive effect, COX-2 level was significantly decreasing (2.3-1.9-fold), VEGF level was significantly decreasing (2.3–1.7-fold); progressive tumor growth was combined with a minor decrease in COX-2 and VEGF (1.5–1.4-fold). Conclusions. Radiation therapy in combination with COX-2 inhibitor enhances the effectiveness of treatment by increasing partial regressions and relapse-free survival. An objective response correlates with COX-2 and VEGF levels, which makes it possible to use them to assess RT effectiveness and decide on further treatment strategy.
No takes yet. Share an insight, caveat, or question.
Bilozor et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: